Eosinophilic asthma Trials in Miami, United States
Conditions / Eosinophilic asthma / Miami, United States
Clinical trials for Eosinophilic asthma investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01290887 | Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma | TERMINATED | PHASE3 |
| NCT05748600 | A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01270464 | A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma | COMPLETED | PHASE3 |
| NCT06750289 | Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment | RECRUITING | PHASE3 |
| NCT04046939 | Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma | COMPLETED | PHASE2 |
| NCT01285323 | A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma | COMPLETED | PHASE3 |
| NCT01508936 | Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma | COMPLETED | PHASE3 |
| NCT05813288 | A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) | TERMINATED | PHASE3 |
| NCT05763121 | A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. | TERMINATED | PHASE3 |
| NCT01287039 | A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma | COMPLETED | PHASE3 |